ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2014

Phase I dose-escalation study of 5-day intermittent oral lapatinib therapy in patients with human epidermal growth factor receptor 2-overexpressing breast cancer.

A Jo Chien et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.